World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
140
Citations
83994
World Ranking
1680
National Ranking
971

Overview

John M. Davis is affiliated with the University of Illinois at Chicago in the United States. Their research focuses primarily on biochemistry, genetics, and molecular biology, with additional work related to agricultural and biological sciences.

The scientist's work spans several subfields, including molecular biology, agronomy and crop science, plant science, cognitive neuroscience, and pharmacology. This interdisciplinary approach supports investigations into topics such as yeasts and rust fungi studies, bioenergy crop production and management, genomics and phylogenetic studies, microbial natural products and biosynthesis, autism spectrum disorder research, adenosine and purinergic signaling, and transgenic plants and their applications.

John M. Davis has published research in various venues, including:

  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of Autism and Developmental Disorders
  • G3 Genes Genomes Genetics
  • The Journal of Clinical Psychiatry
  • mSystems

Notable recent papers authored or co-authored by Davis include:

  • "Efficacy of Sulforaphane in Treatment of Children with Autism Spectrum Disorder: A Randomized Double-Blind Placebo-Controlled Multi-center Trial" (2022) published in the Journal of Autism and Developmental Disorders
  • "NLR diversity and candidate fusiform rust resistance genes in loblolly pine" (2021) published in G3 Genes Genomes Genetics
  • "TaxiBGC: a Taxonomy-Guided Approach for Profiling Experimentally Characterized Microbial Biosynthetic Gene Clusters and Secondary Metabolite Production Potential in Metagenomes" (2022) published in mSystems
  • "Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia" (2025) published in The Journal of Clinical Psychiatry
  • "Effects of transcranial alternating current stimulation on measures of cognition and symptom scores in Chinese patients with schizophrenia" (2025) published in Journal of Psychiatric Research

Throughout these publications, various co-authors have frequently collaborated with Davis. These include:

  • C. Dana Nelson
  • Daniel Ence
  • Jeremy Brawner
  • Jill Wegrzyn
  • Robert C. Smith

Best Publications

  • Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

    Stefan Leucht;Andrea Cipriani;Andrea Cipriani;Loukia Spineli;Dimitris Mavridis

  • Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

    Stefan Leucht;Caroline Corves;Caroline Corves;Dieter Arbter;Rolf R Engel

  • Norepinephrine in Depressive Reactions: A Review

    William E. Bunney;John M. Davis

  • A Meta-analysis of the Efficacy of Second-Generation Antipsychotics

    John M. Davis;Nancy Chen;Ira D. Glick

  • Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: A postmortem brain study

    Alessandro Guidotti;James Auta;John M. Davis;Valeria DiGiorgi Gerevini

  • The DNA sequence of the human X chromosome

    Mark T Ross;Darren V Grafham;Alison J Coffey;Steven Scherer

  • Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study.

    Joseph R Hibbeln;John M Davis;Colin Steer;Pauline Emmett

  • Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania

    Charles L. Bowden;Andrew M. Brugger;Alan C. Swann;Joseph R. Calabrese

  • Physical Health Monitoring of Patients With Schizophrenia

    Stephen R. Marder;Susan M. Essock;Alexander L. Miller;Robert W. Buchanan

  • Omega-3 fatty acids: Evidence basis for treatment and future research in psychiatry

    Marlene P. Freeman;Joseph R. Hibbeln;Katherine L. Wisner;John M. Davis;John M. Davis

  • Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

    Stefan Leucht;Magdolna Tardy;Katja Komossa;Stephan Heres

  • The Altman Self-Rating Mania Scale

    Edward G. Altman;Donald Hedeker;James L. Peterson;John M. Davis

  • Diagnosis and Drug Treatment of Psychiatric Disorders

    Donald F. Klein;John M. Davis

  • A decrease of reelin expression as a putative vulnerability factor in schizophrenia

    Francesco Impagnatiello;Alessandro R. Guidotti;Christine Pesold;Yogesh Dwivedi

  • The Effects of Risperidone on the Five Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American Trials

    Stephen R. Marder;John M. Davis;Guy Chouinard

  • Bulimia. Its incidence and clinical importance in patients with anorexia nervosa.

    Regina C. Casper;Elke D. Eckert;Katherine A. Halmi;Solomon C. Goldberg

  • Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis

    Christine Rummel-Kluge;Katja Komossa;Sandra Schwarz;Heike Hunger

  • Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

    V. Uzunova;Y. Sheline;John M. Davis;A. Rasmusson

  • The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.

    Alan S. Bellack;Charles L. Bowden;Christopher R. Bowie;Matthew J. Byerly

  • Second-generation versus first-generation antipsychotic drugs for schizophrenia : a meta-analysis. Commentary

    Peter Tyrer;Tim Kendall;Stefan Leucht;Caroline Corves

Frequent Co-Authors

Stefan Leucht
Stefan Leucht Technical University of Munich
Ghanshyam N. Pandey
Ghanshyam N. Pandey University of Illinois at Chicago
David S. Janowsky
David S. Janowsky University of California, San Diego
Alessandro Guidotti
Alessandro Guidotti University of Illinois at Chicago
Robert D. Gibbons
Robert D. Gibbons University of Chicago
Andrea Cipriani
Andrea Cipriani University of Oxford
Mark Weiser
Mark Weiser Sheba Medical Center
Dennis R. Grayson
Dennis R. Grayson University of Illinois at Chicago
Henry Sershen
Henry Sershen New York University
Rolf R. Engel
Rolf R. Engel Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider pursuing a career in Medicine in the USA, it's important to know about other rewarding healthcare pathways that can be accessed through flexible, affordable, and accredited online programs. These options can help you break into the healthcare field or advance your current career.

For those interested in pharmaceuticals, online pharmacy school programs offer a convenient route to earning a Doctor of Pharmacy degree. If you’re more interested in the intersection of healthcare and technology, you can prepare for administrative and management roles with accredited rhia certification programs online.

Many students choose to begin their medical careers by earning the cheapest medical coding certification online, which opens doors to high-demand jobs in healthcare facilities, insurance companies, and clinics. Alternatively, if you are a registered nurse looking to take on advanced clinical roles, nurse practitioner programs provide a path to increased responsibility and earning potential.

Exploring these online medical degree programs can help you find the best fit for your professional goals and lifestyle.

Best Scientists Citing John M. Davis

Trending Scientists